|
ABOUT COMPANY
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
|
EARNINGS
Gross Profit (TTM): 224804000
Market Capitalization: 874124000
Operating Margin (TTM): 0.164
PE Ratio: 26.15
PEG Ratio: -2.42
Profit Margin: 0.128
Revenue Per Share (TTM): 4.853
Revenue (TTM): 268316000
Quarterly Earnings Growth YOY: 0.283
Quarterly Revenue Growth YOY: 0.162
Trailing PE: 26.15
|
DIVIDENDS
Diluted EPS (TTM): 0.6
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 46828000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|